BRD4 and cancer: In this study, we explored the potential of utilizing exosomes derived from camel milk as a novel delivery system for improving the bioavailability of the anticancer agent ARV-825, which targets the bromodomain and extra terminal (BET) protein family, specifically BRD4, a critical player in cancer development.